Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Opening of Hong Kong office

21 Feb 2018 07:00

RNS Number : 4502F
Medaphor Group PLC
21 February 2018
 

MedaPhor Group plc

("MedaPhor" or the "Group" or the "Company")

 

Opening of Hong Kong office

 

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that it has opened an office in Hong Kong to facilitate the Group's established reseller network and growing customer base in the Asia-Pacific (APAC) region.

 

The Group now has 18 active reseller partners in this region selling the ScanTrainer, HeartWorks and new BodyWorks Eve simulation portfolio into hospitals and university teaching schools.

 

The new Hong Kong office will support and aim to expand reseller sales, marketing and customer relations across the APAC region and especially in the growing Chinese simulation market.

 

The Company has appointed a local Channel and Product Support Manager, Victor Kwan, to be permanently based out of the Hong Kong office. Victor brings with him over 10 years of experience working in product marketing and management, seven of which were spent in the medical simulation industry.

 

Stuart Gall, Chief Executive Officer at MedaPhor, comments:

"We now have a well-established reseller channel in APAC and are looking to cement our presence in the region. With its central location and excellent transport links, our new Hong Kong office will enable us to have a full-time local presence in these important and growing markets, as we look to continue the expansion and growth in the APAC ultrasound software and simulation market."

 

Enquiries:

 

MedaPhor Group plc

investors.medaphor.com

Stuart Gall, CEO

Ian Whittaker, COO

Tel: +44 (0)29 2075 6534

 

 

Cenkos Securities

Tel: +44 (0)20 7397 8900

Camilla Hume/Bobbie Hilliam (Nominated Advisor)

 

Michael Johnson / Julian Morse (Corporate Broking)

 

 

 

Walbrook PR

Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001

 

 

About MedaPhor (investors.medaphor.com)

 

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops artificial intelligence-based clinical image analysis software tools, augmented reality-based needle guidance software and advanced hi-fidelity haptic and manikin-based training simulators for medical practitioners.

 Based in Cardiff and Oxford in the UK and Atlanta in the US, MedaPhor is split into two divisions:

 Intelligent Ultrasound Simulation and Training

 

Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks Echocardiography simulator platform and BodyWorks Eve the Point of Care Ultrasound (PoCUS) simulator. Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

Intelligent Ultrasound Clinical Support

 

Focuses on augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav which uses machine-learning based algorithms to automatically identify and grade ultrasound images to provide scan assessment and audit of obstetric scanning. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

 

Some products in the pipeline may require US FDA approval, as such this material should be considered informational only and does not constitute an offer to sell, or infer, claims or benefits.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDBLFLVLFXBBK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.